SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-044111
Filing Date
2012-08-09
Accepted
2012-08-09 16:57:54
Documents
6
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v320662_10q.htm 10-Q 649510
2 EXHIBIT 3.1 v320662_ex3-1.htm EX-3.1 73234
3 EXHIBIT 31.1 v320662_ex31-1.htm EX-31.1 10433
4 EXHIBIT 31.2 v320662_ex31-2.htm EX-31.2 10294
5 EXHIBIT 32.1 v320662_ex32-1.htm EX-32.1 4017
6 EXHIBIT 32.2 v320662_ex32-2.htm EX-32.2 3861
  Complete submission text file 0001144204-12-044111.txt   752640
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 121021097
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences